Skip to main content
. 2022 Dec 30;30(1):545–558. doi: 10.3390/curroncol30010043

Table 5.

Dependency between stage of the disease and EMVI (broken down into groups by the level of LMR, NLR and PLR).

Stage, n (%) EMVI − EMVI + p
LMR ≤ median
II–III A 29 (58.0) 15 (38.5) 0.002
III B 19 (38.0) 11 (28.2)
III C 2 (4.0) 13 (33.3)
LMR > median
II–III A 30 (57.7) 10 (27.0) 0.002
III B 19 (36.5) 16 (43.2)
III C 3 (5.8) 11 (29.7)
NLR ≤ median
II–III A 30 (55.6) 12 (34.3) 0.008
III B 21 (38.9) 13 (37.1)
III C 3 (5.6) 10 (28.6)
NLR > median
II–III A 29 (60.4) 13 (31.7) 0.001
III B 17 (35.4) 14 (34.1)
III C 2 (4.2) 14 (34.1)
PLR ≤ median
II–III A 31 (56.4) 10 (29.4) 0.010
III B 21 (38.2) 16 (47.1)
III C 3 (5.5) 8 (23.5)
PLR > median
II–III A 28 (59.6) 15 (35.7) <0.001
III B 17 (36.2) 11 (26.2)
III C 2 (4.3) 16 (38.1)

Bold font indicates statistical significance. EMVI, extramural vascular invasion; LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-monocyte ratio; PLR, platelet-to-lymphocyte ratio. Data presented as n (% of EMVI−/ EMVI + group). Dependencies were analysed with chi-square test.